Security key
87583X109
Tango Therapeutics, Inc. - Common stock, par value $0.001 per share (TNGX)
CUSIP: 87583X109
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Total 13F shares
- 68,157,717
- Total 13F value
- $246,729,459
- Share change
- -2,311,660
- SEC-reported price per share
- $3.62
- Number of holders
- 86
- Value change
- -$12,119,590
- Number of buys
- 41
- Number of sells
- 28
- Shares outstanding
- 162,373,380
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
86
Top holders
10
TNGX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Tango Therapeutics, Inc. SEC filings
Tango Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87583X109
Recent filing periods:
Ownership snapshot
Top reported holders of TNGX - Tango Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BCTG Holdings, LLC
Disclosed value leader
TRV GP IV, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2022
3/4/5
13F
Highest disclosed value: $87,719,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
TRV GP IV, LLC has the largest disclosed position value at $87.72M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TRV GP IV, LLC's linked filing trail.
Disclosed position value
Top 5
BCTG Holdings, LLC
$58.64M
Braslyn Ltd.
$226.2K
TRV GP IV, LLC
$87.72M
FMR LLC
$34.57M
Boxer Capital, LLC
$31.13M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BCTG Holdings, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$58,642,879
6,988,450 shares
|
— | 10 Aug 2021 |
| Braslyn Ltd. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$226,241
26,961 shares
|
— | 10 Aug 2021 |
| TRV GP IV, LLC |
13F
Company
|
—
denominator unverified
|
$87,719,000
19,363,975 shares
|
— | 30 Jun 2022 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$34,572,000
7,631,917 shares
|
— | 30 Jun 2022 |
| Boxer Capital, LLC |
13F
Company
|
—
denominator unverified
|
$31,129,000
6,871,642 shares
|
— | 30 Jun 2022 |
| Cormorant Asset Management, LP |
13F
Company
|
—
denominator unverified
|
$20,421,000
4,507,843 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
86
Shares
68,157,717
Rows available
86
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
76
Q3 2022 holders
86
Holder diff
10
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend